Filter by Type

Press Release (53)

Filter by Categories

Cancer (18)
Cardiovascular System (14)
Cell Biology (14)
Endocrinology & Metabolism (17)
Epigenetics, Transcription, & Translation (13)
Forensic Chemistry & Toxicology (22)
Immunology & Inflammation (26)
Infectious Disease (18)
Lipid Biochemistry (25)
Lipid-Based Drug Delivery (6)
Neuroscience (15)
Oxidative Stress & Reactive Species (12)
Services (14)
Toxicology (13)
Displaying 1 - 25 of 53 Results

​Successful Pilot Scale Run with Cayman Chemical Validates eXoZymes' Technology and Scalability

Press Release from 2026-03-18

Today, eXoZymes announced an important validation and de-risking milestone for its cell-free biomanufacturing platform: An independent partner, Cayman Chemical, successfully ran eXoZymes’ technology at pilot scale and achieved results consistent with - and in some cases exceeding - earlier internal runs.

New Partnership Brings Next-Generation Cell Isolation Solutions to Researchers Advancing Cell and Gene Therapy Development

Press Release from 2025-09-24

Cayman Chemical, a global provider of life science research tools, and Akadeum Life Sciences, a leader in buoyancy-based cell separation technology, announced today a distribution partnership to expand access to Akadeum's next-generation cell isolation technology for cell and gene therapy development.

Cayman Chemical and Curapath Partner to Provide Wider Access to PEG-Free Shielding Lipids for Lipid Nanoparticles

Press Release from 2025-09-03

ANN ARBOR, MI, SEPTEMBER 03, 2025—Two leaders in lipid nanoparticle (LNP) development have partnered to make PEG-free shielding lipids available to researchers advancing LNPs for non-viral drug delivery, gene therapy, mRNA vaccines, and biologic therapies.

CABRI Fellowship Program Opens for Undergraduate Research Applicants

Press Release from 2025-08-05

The Cayman Biomedical Research Institute (CABRI) has announced that applications are now open for our undergraduate research fellowships. Applications may be submitted on the CABRI website from August 11th 2025 through September 29th, 2025.

CABRI Announces Fellowship Opportunities for Undergraduate Research Traineeships

Press Release from 2024-09-11

The Cayman Biomedical Research Institute (CABRI) is pleased to announce that applications for our undergraduate fellowships are open. Undergraduate fellowship applications may be submitted on the CABRI website from September 10th to October 4th, 2024, and awardees will be notified by October 18th, 2024.

Cayman and Certest Announce Partnership, Expanding Access to Ionizable Lipids for Lipid Nanoparticles

Press Release from 2024-08-21

Cayman Chemical and Certest Pharma have announced a new partnership to make Certest ionizable lipids available for LNP research through Cayman’s online catalog and global network of distributors.

Cayman Chemical Expands Molecular Diagnostic Research Offerings Through Partnership with PCRassays.com

Press Release from 2024-06-05

Cayman partnered with PCRassays.com to widen their portfolio of molecular-based detection kits. PCRassays.com offers more than 200 qPCR-based assays for infectious diseases, over 50 of which are multiplex assays, including panels for wound, upper respiratory, urinary tract, and sexually transmitted infections.

Cayman Chemical Introduces LipidLaunch™, Expands Portfolio of Lipid Nanoparticle Research Tools to Support Advances in RNA Therapies

Press Release from 2024-02-22

Cayman Chemical, a leading supplier of research tools for lipid nanoparticles (LNPs), announced today the introduction of LipidLaunch™ research-ready LNPs and reagent kits. The LipidLaunch™ product line is the latest addition to the company's portfolio of LNP research tools and reflects the company's legacy of providing high-quality lipids for academic, pharma, and biotech researchers worldwide.

Cayman Chemical Introduces a New Tool to Study Protein-Lipid Interactions

Press Release from 2023-09-20

Cayman Chemical, a leading supplier of bioactive lipids, has developed Cayman LipiDOT Strips™ as a research tool for the rapid identification of protein-lipid interactions. This new tool allows researchers to maximize the information gained from early protein-lipid interaction screening campaigns, giving researchers greater insight into protein-lipid interactions while being simple to perform, low cost, and easily completed in a single day.

Cayman Chemical Receives CEP for Latanoprost API from EDQM

Press Release from 2023-09-12

Cayman Chemical, a world leader in the manufacture of prostaglandins for both research use and as active pharmaceutical ingredients (APIs), has been granted a CEP for its latanoprost API. Cayman Chemical is the first company in the USA to receive a CEP for latanoprost.

Cayman and Navinci Announce Strategic Partnership, Expanding Access to Next-Generation Tools for Spatial Proteomics

Press Release from 2023-07-05

Cayman and Navinci have partnered to bring next-generation proximity ligation-based solutions for spatial proteomics to US- and Canada-based researchers.

Fentanyl Analog Screening Kit Now Available Internationally Through Partnership Between Cayman, CDC, and INCB

Press Release from 2023-05-31

Cayman has received authorization for a first-of-its-kind distribution campaign to supply Fentanyl Analog Screening (FAS) Kits to authorized forensic institutions worldwide in an effort to disrupt the global production and supply of synthetic opioids.

New Traceable Opioid Material® Kit Expands Coverage to Other Emerging Drugs of Concern in Seized Samples and Toxicological Casework

Press Release from 2023-04-26

The new Fentanyl Analog Screening Kit - Emergent Drug Panel is now available from Cayman. It contains 60 emerging drugs of abuse typically detected alongside fentanyl and its analogs to further expand laboratory screening and surveillance capabilities.

CABRI Awards $40,000 in Fellowships to Ten Undergraduate Researchers

Press Release from 2022-12-12

Cayman joins the Cayman Biomedical Research Institute (CABRI) in recognizing the ten undergraduate students who have been awarded fellowships by CABRI for the 2022-2023 academic year. The fellowship awards are given to talented undergraduates that are pursuing a research project of their own under the guidance of a faculty mentor.

DEADLINE EXTENDED: CABRI Announces Undergraduate Fellowships and Scholarship Program

Press Release from 2022-08-18

The Cayman Biomedical Research Institute (CABRI) is accepting applications from undergraduate students who have been offered an unpaid laboratory research position under an accredited principal investigator. Applications will be accepted from August 22 until October 2, 2022.

Specialized Pro-Resolving Mediator ELISA Kit Notice

Press Release from 2022-08-11

In light of the ongoing discussions on the detection of specialized pro-resolving mediators (SPMs) in the scientific community, researchers are advised to validate results from this ELISA with a secondary detection method or to clearly report the limitations of this ELISA in their publications.

Cayman Receives Grant to Evaluate Use of KMN-159 to Accelerate Dental Implant Osseointegration

Press Release from 2021-09-16

The National Institute of Dental and Craniofacial Research has awarded Cayman Chemical with a $1,700,500 grant to explore Cayman’s patented small molecule bone repair agent KMN-159 as the active pharmaceutical ingredient (API) in a drug-device combination to improve the mechanical anchorage of dental titanium implants into the jawbone. The studies proposed in this grant aim to address several clinical challenges for dental implant therapy, especially in patients with low bone density conditions such as osteoporosis.

​Rare Diseases Research Funded by $345,757 in Grants from CABRI

Press Release from 2021-08-03

In its ongoing commitment to funding research for new treatments for rare diseases, Cayman Biomedical Research Institute (CABRI) has announced its principal investigator grant recipients for the 2021 academic year.

​$5K Grants Available for Undergraduate Students Seeking Research Experience

Press Release from 2021-08-03

Cayman Biomedical Research Institute (CABRI) will be accepting applications from undergraduate students who have been offered an unpaid laboratory research position under an accredited principal investigator. Applications will be accepted August 23 – September 19, 2021.

SM-102 for Research Use Only (RUO)

Press Release from 2021-05-19

Cayman develops and manufactures chemical compounds for research use only (RUO) and has a separate business division that produces small molecules as Active Pharmaceutical Ingredients (API) for human and veterinary use. Read more about our product SM-102 and how the information on the SDS should be interpreted.

Powerful, New Multiplex ELISA for Autoantibody Detection

Press Release from 2021-05-11

Ann Arbor, MI, May 11, 2021—Cayman Chemical's new Q-Plex™ Autoantibody Detection 10-Plex Panel, developed in collaboration with Quansys Biosciences, offers standardized, multiplex capabilities for the concurrent analysis of ten prominent analytes associated with rheumatoid arthritis or other autoimmune diseases.

Cayman Adds Nordic BioSite as Trusted Distributor

Press Release from 2021-02-08

Cayman products are now available through Nordic BioSite in Denmark, Finland, Iceland, Norway, Sweden, and the Baltic countries as well as Russia. Headquartered in Täby, Sweden, Nordic BioSite’s sales and technical support teams operate with a ‘By Your Side’ mission to assist customers in finding the right products for their research.

​Cayman Breaks Ground on State-of-the-Art Facility Projecting Future Growth in R&D

Press Release from 2020-11-05

Cayman held a groundbreaking ceremony to start the buildout of a $20 million research and development facility at its headquarters in Ann Arbor, MI.

​Cayman Receives SBIR Grant for Alzheimer’s Research

Press Release from 2020-10-08

The National Institute on Aging (NIA) has awarded Cayman Chemical with a Phase II Small Business Innovation Research (SBIR) grant to develop an assay platform and novel antibodies to support the treatment, prevention, and early diagnosis of Alzheimer’s disease and other tauopathies.

​Grants Available for Undergraduate Students Seeking Research Experience

Press Release from 2020-08-17

Cayman Biomedical Research Institute (CABRI) is now accepting applications from undergraduate students who have been offered an unpaid laboratory research position under an accredited principal investigator. Applications will be accepted until September 20, 2020.

Displaying 1 - 25 of 53 Results